2-Azetidinone – A new profile of various pharmacological activities

2-Azetidinone, a β-lactam four member heterocyclic compound involved in research aimed to evaluate new products that possess interesting biological activities. These compounds reported for their antimicrobial and antifungal activities. Successful introduction of aztreonam as a potent inhibitor of ce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medicinal chemistry 2010-12, Vol.45 (12), p.5541-5560
Hauptverfasser: Mehta, Parul D., Sengar, N.P.S., Pathak, A.K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5560
container_issue 12
container_start_page 5541
container_title European journal of medicinal chemistry
container_volume 45
creator Mehta, Parul D.
Sengar, N.P.S.
Pathak, A.K.
description 2-Azetidinone, a β-lactam four member heterocyclic compound involved in research aimed to evaluate new products that possess interesting biological activities. These compounds reported for their antimicrobial and antifungal activities. Successful introduction of aztreonam as a potent inhibitor of cephalosporinase and ezetimibe as a cholesterol absorption inhibitor proved potential of 2-azetidinone moiety. Subsequently 2-azetidinones were highlighted as a potent mechanism based inhibitor of several enzymes like human tryptase, chymase, thrombin, leukocyte elastase, human cytomegalovirus protease and serine protease enzyme. These derivatives also known to possess antitubercular, anti-inflammatory, antitumor, anti-HIV, antiparkinsonian, antidiabetic and vasopressin V1a antagonist activity. The present review article focuses on the pharmacological profile of 2-azetidinones with their potential activities. 2-Azetidinone and their derivatives occupy a central place in medicinal chemistry due to their diverse and broad pharmacological profile. This article focuses on the various pharmacological profile of 2-azetidinone scaffold and development of novel derivatives with their potential activity. [Display omitted]
doi_str_mv 10.1016/j.ejmech.2010.09.035
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_812134349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0223523410006835</els_id><sourcerecordid>812134349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-bfc8100c1ecd56735f2334f229a307ad5256ce05269eda63f0d13e2eb93e15593</originalsourceid><addsrcrecordid>eNp9kMtKA0EQRRtRTHz8gchsxNXE6tdMZiOEEB8QcKPrptNTbTrMI3ZPIrryH_xDv8QOibpzVVCcW3U5hJxRGFCg2dVigIsazXzAIK6gGACXe6RP82yYcibFPukDYzyVjIseOQphAQAyAzgkPQZFDsNC9smEpaN37FzpmrbB5OvjMxklDb4mS99aV2HS2mStvWtXIVnOta-1aav22RldJdp0bu06h-GEHFhdBTzdzWPydDN5HN-l04fb-_Fomhoh8y6dWTOkAIaiKWWWc2kZ58IyVmgOuS4lk5lBkCwrsNQZt1BSjgxnBUcqZcGPyeX2bmz3ssLQqdoFg1WlG4wN1ZAyygUXG1JsSePbEDxatfSu1v5NUVAbf2qhtv7Uxp-CQkV_MXa-e7Ca1Vj-hn6EReBiB-gQHVivG-PCH8dFLqigkbvechh1rB16FYzDxmDpPJpOla37v8k30UqPtQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>812134349</pqid></control><display><type>article</type><title>2-Azetidinone – A new profile of various pharmacological activities</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Mehta, Parul D. ; Sengar, N.P.S. ; Pathak, A.K.</creator><creatorcontrib>Mehta, Parul D. ; Sengar, N.P.S. ; Pathak, A.K.</creatorcontrib><description>2-Azetidinone, a β-lactam four member heterocyclic compound involved in research aimed to evaluate new products that possess interesting biological activities. These compounds reported for their antimicrobial and antifungal activities. Successful introduction of aztreonam as a potent inhibitor of cephalosporinase and ezetimibe as a cholesterol absorption inhibitor proved potential of 2-azetidinone moiety. Subsequently 2-azetidinones were highlighted as a potent mechanism based inhibitor of several enzymes like human tryptase, chymase, thrombin, leukocyte elastase, human cytomegalovirus protease and serine protease enzyme. These derivatives also known to possess antitubercular, anti-inflammatory, antitumor, anti-HIV, antiparkinsonian, antidiabetic and vasopressin V1a antagonist activity. The present review article focuses on the pharmacological profile of 2-azetidinones with their potential activities. 2-Azetidinone and their derivatives occupy a central place in medicinal chemistry due to their diverse and broad pharmacological profile. This article focuses on the various pharmacological profile of 2-azetidinone scaffold and development of novel derivatives with their potential activity. [Display omitted]</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2010.09.035</identifier><identifier>PMID: 20970895</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Kidlington: Elsevier Masson SAS</publisher><subject>2-Azetidinone ; Animals ; Anti-Infective Agents - chemistry ; Anti-Infective Agents - pharmacology ; Antifungal Agents - chemistry ; Antifungal Agents - pharmacology ; Antiparkinson Agents - chemistry ; Antiparkinson Agents - pharmacology ; Azetidines - chemistry ; Azetidines - pharmacology ; Biological activity ; Biological and medical sciences ; Four membered heterocyclic ring ; Humans ; Hypoglycemic Agents - chemistry ; Hypoglycemic Agents - pharmacology ; Medical sciences ; Miscellaneous ; Pharmacology. Drug treatments ; β-Lactam</subject><ispartof>European journal of medicinal chemistry, 2010-12, Vol.45 (12), p.5541-5560</ispartof><rights>2010 Elsevier Masson SAS</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-bfc8100c1ecd56735f2334f229a307ad5256ce05269eda63f0d13e2eb93e15593</citedby><cites>FETCH-LOGICAL-c457t-bfc8100c1ecd56735f2334f229a307ad5256ce05269eda63f0d13e2eb93e15593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejmech.2010.09.035$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=23474141$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20970895$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mehta, Parul D.</creatorcontrib><creatorcontrib>Sengar, N.P.S.</creatorcontrib><creatorcontrib>Pathak, A.K.</creatorcontrib><title>2-Azetidinone – A new profile of various pharmacological activities</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>2-Azetidinone, a β-lactam four member heterocyclic compound involved in research aimed to evaluate new products that possess interesting biological activities. These compounds reported for their antimicrobial and antifungal activities. Successful introduction of aztreonam as a potent inhibitor of cephalosporinase and ezetimibe as a cholesterol absorption inhibitor proved potential of 2-azetidinone moiety. Subsequently 2-azetidinones were highlighted as a potent mechanism based inhibitor of several enzymes like human tryptase, chymase, thrombin, leukocyte elastase, human cytomegalovirus protease and serine protease enzyme. These derivatives also known to possess antitubercular, anti-inflammatory, antitumor, anti-HIV, antiparkinsonian, antidiabetic and vasopressin V1a antagonist activity. The present review article focuses on the pharmacological profile of 2-azetidinones with their potential activities. 2-Azetidinone and their derivatives occupy a central place in medicinal chemistry due to their diverse and broad pharmacological profile. This article focuses on the various pharmacological profile of 2-azetidinone scaffold and development of novel derivatives with their potential activity. [Display omitted]</description><subject>2-Azetidinone</subject><subject>Animals</subject><subject>Anti-Infective Agents - chemistry</subject><subject>Anti-Infective Agents - pharmacology</subject><subject>Antifungal Agents - chemistry</subject><subject>Antifungal Agents - pharmacology</subject><subject>Antiparkinson Agents - chemistry</subject><subject>Antiparkinson Agents - pharmacology</subject><subject>Azetidines - chemistry</subject><subject>Azetidines - pharmacology</subject><subject>Biological activity</subject><subject>Biological and medical sciences</subject><subject>Four membered heterocyclic ring</subject><subject>Humans</subject><subject>Hypoglycemic Agents - chemistry</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pharmacology. Drug treatments</subject><subject>β-Lactam</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKA0EQRRtRTHz8gchsxNXE6tdMZiOEEB8QcKPrptNTbTrMI3ZPIrryH_xDv8QOibpzVVCcW3U5hJxRGFCg2dVigIsazXzAIK6gGACXe6RP82yYcibFPukDYzyVjIseOQphAQAyAzgkPQZFDsNC9smEpaN37FzpmrbB5OvjMxklDb4mS99aV2HS2mStvWtXIVnOta-1aav22RldJdp0bu06h-GEHFhdBTzdzWPydDN5HN-l04fb-_Fomhoh8y6dWTOkAIaiKWWWc2kZ58IyVmgOuS4lk5lBkCwrsNQZt1BSjgxnBUcqZcGPyeX2bmz3ssLQqdoFg1WlG4wN1ZAyygUXG1JsSePbEDxatfSu1v5NUVAbf2qhtv7Uxp-CQkV_MXa-e7Ca1Vj-hn6EReBiB-gQHVivG-PCH8dFLqigkbvechh1rB16FYzDxmDpPJpOla37v8k30UqPtQ</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Mehta, Parul D.</creator><creator>Sengar, N.P.S.</creator><creator>Pathak, A.K.</creator><general>Elsevier Masson SAS</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>2-Azetidinone – A new profile of various pharmacological activities</title><author>Mehta, Parul D. ; Sengar, N.P.S. ; Pathak, A.K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-bfc8100c1ecd56735f2334f229a307ad5256ce05269eda63f0d13e2eb93e15593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>2-Azetidinone</topic><topic>Animals</topic><topic>Anti-Infective Agents - chemistry</topic><topic>Anti-Infective Agents - pharmacology</topic><topic>Antifungal Agents - chemistry</topic><topic>Antifungal Agents - pharmacology</topic><topic>Antiparkinson Agents - chemistry</topic><topic>Antiparkinson Agents - pharmacology</topic><topic>Azetidines - chemistry</topic><topic>Azetidines - pharmacology</topic><topic>Biological activity</topic><topic>Biological and medical sciences</topic><topic>Four membered heterocyclic ring</topic><topic>Humans</topic><topic>Hypoglycemic Agents - chemistry</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pharmacology. Drug treatments</topic><topic>β-Lactam</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mehta, Parul D.</creatorcontrib><creatorcontrib>Sengar, N.P.S.</creatorcontrib><creatorcontrib>Pathak, A.K.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mehta, Parul D.</au><au>Sengar, N.P.S.</au><au>Pathak, A.K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>2-Azetidinone – A new profile of various pharmacological activities</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>45</volume><issue>12</issue><spage>5541</spage><epage>5560</epage><pages>5541-5560</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>2-Azetidinone, a β-lactam four member heterocyclic compound involved in research aimed to evaluate new products that possess interesting biological activities. These compounds reported for their antimicrobial and antifungal activities. Successful introduction of aztreonam as a potent inhibitor of cephalosporinase and ezetimibe as a cholesterol absorption inhibitor proved potential of 2-azetidinone moiety. Subsequently 2-azetidinones were highlighted as a potent mechanism based inhibitor of several enzymes like human tryptase, chymase, thrombin, leukocyte elastase, human cytomegalovirus protease and serine protease enzyme. These derivatives also known to possess antitubercular, anti-inflammatory, antitumor, anti-HIV, antiparkinsonian, antidiabetic and vasopressin V1a antagonist activity. The present review article focuses on the pharmacological profile of 2-azetidinones with their potential activities. 2-Azetidinone and their derivatives occupy a central place in medicinal chemistry due to their diverse and broad pharmacological profile. This article focuses on the various pharmacological profile of 2-azetidinone scaffold and development of novel derivatives with their potential activity. [Display omitted]</abstract><cop>Kidlington</cop><pub>Elsevier Masson SAS</pub><pmid>20970895</pmid><doi>10.1016/j.ejmech.2010.09.035</doi><tpages>20</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2010-12, Vol.45 (12), p.5541-5560
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_812134349
source Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE
subjects 2-Azetidinone
Animals
Anti-Infective Agents - chemistry
Anti-Infective Agents - pharmacology
Antifungal Agents - chemistry
Antifungal Agents - pharmacology
Antiparkinson Agents - chemistry
Antiparkinson Agents - pharmacology
Azetidines - chemistry
Azetidines - pharmacology
Biological activity
Biological and medical sciences
Four membered heterocyclic ring
Humans
Hypoglycemic Agents - chemistry
Hypoglycemic Agents - pharmacology
Medical sciences
Miscellaneous
Pharmacology. Drug treatments
β-Lactam
title 2-Azetidinone – A new profile of various pharmacological activities
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A40%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=2-Azetidinone%20%E2%80%93%20A%20new%20profile%20of%20various%20pharmacological%20activities&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=Mehta,%20Parul%20D.&rft.date=2010-12-01&rft.volume=45&rft.issue=12&rft.spage=5541&rft.epage=5560&rft.pages=5541-5560&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2010.09.035&rft_dat=%3Cproquest_cross%3E812134349%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=812134349&rft_id=info:pmid/20970895&rft_els_id=S0223523410006835&rfr_iscdi=true